About Dizal Pharma
Dizal Pharma is a company based in Pudong (China) founded in 2017.. Dizal Pharma has raised $100 million across 1 funding round from investors including SANY Group, Lilly Asia Ventures and Trinity Innovation Fund. Dizal Pharma operates in a competitive market with competitors including AmerisourceBergen, Quanyuantang Pharmacy, Guiyang Xintian Pharmaceutical, Sinopharm Online and Jiuzhitang, among others.
- Headquarter Pudong, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$100 M (USD)
in 1 rounds
-
Latest Funding Round
$100 M (USD), Series A
Aug 20, 2020
-
Investors
SANY Group
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Dizal Pharma
Dizal Pharma has successfully raised a total of $100M through 1 strategic funding round. The most recent funding activity was a Series A round of $100 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $100.0M
-
First Round
First Round
(20 Aug 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series A - Dizal Pharma | Valuation | Lilly Asia Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dizal Pharma
Dizal Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include SANY Group, Lilly Asia Ventures and Trinity Innovation Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on biotech innovation investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Manufacturer of construction & mining equipment, port, and oil drilling machinery
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dizal Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dizal Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dizal Pharma Comparisons
Competitors of Dizal Pharma
Dizal Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Quanyuantang Pharmacy, Guiyang Xintian Pharmaceutical, Sinopharm Online and Jiuzhitang, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Medical and pharmaceutical products are retailed offline and online.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical company in China
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products are sold via an e-commerce platform in China.
|
|
| domain | founded_year | HQ Location |
Distributor of pharmaceutical products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dizal Pharma
Frequently Asked Questions about Dizal Pharma
When was Dizal Pharma founded?
Dizal Pharma was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Dizal Pharma located?
Dizal Pharma is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Is Dizal Pharma a funded company?
Dizal Pharma is a funded company, having raised a total of $100M across 1 funding round to date. The company's 1st funding round was a Series A of $100M, raised on Aug 20, 2020.
What does Dizal Pharma do?
Dizal Pharma was founded in 2017 and is headquartered in Pudong, China. Operations are centered in the biopharmaceutical sector, with emphasis on discovering and developing novel small-molecule drugs for oncology and other unmet medical needs. Clinical-stage assets are advanced through partnerships and internal RD efforts, targeting global markets while maintaining a base in Asia. Limited public details are available on specific services or revenue streams.
Who are the top competitors of Dizal Pharma?
Dizal Pharma's top competitors include AmerisourceBergen, Guiyang Xintian Pharmaceutical and Quanyuantang Pharmacy.
Who are Dizal Pharma's investors?
Dizal Pharma has 4 investors. Key investors include SANY Group, Lilly Asia Ventures, Trinity Innovation Fund, and HongShan.